BCL-2 polyclonal, anti-human

Quantity: 100 µg

Background:
Immunoreactive BCL2 protein in the neoplastic cells of almost all follicular lymphomas whereas no BCL2 protein was detected in follicles affected by nonneoplastic processes or in normal lymphoid tissue. Every tumor with molecular-genetic evidence of t(14;18) translocation expressed detectable levels of BCL2 protein, regardless of whether the breakpoint was located in or at a distance from the BCL2 gene. Overexpression of BCL2 blocks the apoptotic death of a pro-B-lymphocyte cell line.

Description:
Rabbit IgG polyclonal antibody for Apoptosis regulator Bcl-2 (BCL2) detection. Tested with WB, ELISA, Neu, IP in Human.

Synonyms:
Apoptosis regulator Bcl2 antibody, B cell CLL antibody, B cell lymphoma 2 antibody, B cell lymphoma protein 2 alpha isoform antibody, B cell lymphoma protein 2 antibody, B-cell CLL/lymphoma 2 antibody, B-cell leukemia/lymphoma 2 antibody, Bcl 2 antibody, bcl2a antibody, Leukemia /lymphoma, B-cell, 2 antibody, Oncogene B cell leukemia 2 antibody, Oncogene B-cell leukemia 2 antibody

Isotype: Rabbit polyclonal IgG

Immunogen:
E. coli-derived human BCL-2 recombinant protein(Position: M1-D211).

Form: Lyophilized; Each vial contains 0.9mg NaCl, 0.2mg Na2HPO4, 0.05mg NaN3.

Specificity:
No cross reactivity with other proteins.

Reactivity: Reacts with: human

Applications: WB, ELISA, Neu, IP

Reconstitution:
Add 0.2ml of distilled water will yield a concentration of 500ug/ml.

Storage: At -20˚C for one year. After reconstitution, at 4˚C for one month. It can also be aliquotted and stored frozen at -20˚C for a longer time. Avoid repeated freezing and thawing.